| Host and environmental factors influencing individual human cytokine responses R Ter Horst, M Jaeger, SP Smeekens, M Oosting, MA Swertz, Y Li, ... Cell 167 (4), 1111-1124. e13, 2016 | 458 | 2016 |
| Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial HJEM Janssens, M Janssen, EH Van de Lisdonk, PLCM van Riel, ... The Lancet 371 (9627), 1854-1860, 2008 | 432 | 2008 |
| A diagnostic rule for acute gouty arthritis in primary care without joint fluid analysis HJEM Janssens, J Fransen, EH Van de Lisdonk, PLCM van Riel, ... Archives of Internal Medicine 170 (13), 1120-1126, 2010 | 298 | 2010 |
| Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study DM Gerlag, M Safy, KI Maijer, MW Tang, SW Tas, MJF Starmans-Kool, ... Annals of the rheumatic diseases 78 (2), 179-185, 2019 | 219 | 2019 |
| Randomised placebo-controlled study of stopping second-line drugs in rheumatoid arthritis S ten Wolde, FC Breedveld, BAC Dijkmans, J Hermans, ... The Lancet 347 (8998), 347-352, 1996 | 202 | 1996 |
| Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial V Klück, L Tim, M Janssen, A Comarniceanu, M Efdé, IW Tengesdal, ... The Lancet Rheumatology 2 (5), e270-e280, 2020 | 152 | 2020 |
| Study for updated gout classification criteria: identification of features to classify gout WJ Taylor, J Fransen, TL Jansen, N Dalbeth, HR Schumacher, M Brown, ... Arthritis care & research 67 (9), 1304-1315, 2015 | 150 | 2015 |
| Systemic corticosteroids for acute gout HJ Janssens, PLBJ Lucassen, FA Van de Laar, M Janssen, ... Cochrane Database of Systematic Reviews, 2008 | 150 | 2008 |
| GWAS of clinically defined gout and subtypes identifies multiple susceptibility loci that include urate transporter genes A Nakayama, H Nakaoka, K Yamamoto, M Sakiyama, A Shaukat, ... Annals of the rheumatic diseases 76 (5), 869-877, 2017 | 130 | 2017 |
| Performance of ultrasound in the diagnosis of gout in a multicenter study: comparison with monosodium urate monohydrate crystal analysis as the gold standard A Ogdie, WJ Taylor, T Neogi, J Fransen, TL Jansen, HR Schumacher, ... Arthritis & Rheumatology 69 (2), 429-438, 2017 | 123 | 2017 |
| Gout, just a nasty event or a cardiovascular signal? A study from primary care H Janssens, EH Van de Lisdonk, H Bor, HJM Van Den Hoogen, ... Family practice 20 (4), 413-416, 2003 | 122 | 2003 |
| Demographic, clinical and antibody characteristics of patients with digital ulcers in systemic sclerosis: data from the DUO Registry CP Denton, T Krieg, L Guillevin, B Schwierin, D Rosenberg, M Silkey, ... Annals of the rheumatic diseases 71 (5), 718-721, 2012 | 117 | 2012 |
| Anakinra for the treatment of acute gout flares: a randomized, double-blind, placebo-controlled, active-comparator, non-inferiority trial CA Janssen, MAH Oude Voshaar, HE Vonkeman, TLTA Jansen, ... Rheumatology 58 (8), 1344-1352, 2019 | 101 | 2019 |
| Limited validity of the American College of Rheumatology criteria for classifying patients with gout in primary care HJEM Janssens, M Janssen, EH Van de Lisdonk, J Fransen, ... Annals of the rheumatic diseases 69 (6), 1097-1102, 2010 | 95 | 2010 |
| Post‐streptococcal reactive arthritis: a clinical and serological description, revealing its distinction from acute rheumatic fever TLTA Jansen, M Janssen, AJL Jong, MEC Jeurissen Journal of internal medicine 245 (3), 261-267, 1999 | 94 | 1999 |
| Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout D Bursill, WJ Taylor, R Terkeltaub, A Abhishek, AK So, AB Vargas-Santos, ... Annals of the rheumatic diseases 78 (11), 1592-1600, 2019 | 93 | 2019 |
| Gout, Hyperuricemia, and Crystal‐Associated Disease Network Consensus Statement regarding labels and definitions for disease elements in gout D Bursill, WJ Taylor, R Terkeltaub, M Kuwabara, TR Merriman, R Grainger, ... Arthritis care & research 71 (3), 427-434, 2019 | 93 | 2019 |
| Gout, not induced by diuretics? A case-control study from primary care HJEM Janssens, EH van de Lisdonk, M Janssen, HJM van den Hoogen, ... Annals of the rheumatic diseases 65 (8), 1080-1083, 2006 | 93 | 2006 |
| Therapeutic drug monitoring of A77 1726, the active metabolite of leflunomide: serum concentrations predict response to treatment in patients with rheumatoid arthritis EN Van Roon, TLTA Jansen, M Van De Laar, M Janssen, JP Yska, ... Annals of the rheumatic diseases 64 (4), 569-574, 2005 | 76 | 2005 |
| Gout Is a Chronic Inflammatory Disease in Which High Levels of Interleukin‐8 (CXCL8), Myeloid‐Related Protein 8/Myeloid‐Related Protein 14 Complex, and an Altered Proteome Are … LBE Kienhorst, E van Lochem, W Kievit, N Dalbeth, ME Merriman, ... Arthritis & Rheumatology 67 (12), 3303-3313, 2015 | 68 | 2015 |
